Weil Company, Inc. Bristol Myers Squibb CO Transaction History

Weil Company, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $54,131 - $70,609	-1,100 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $47,047 - $55,781	1,100 New	1,100 $55,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.